Yasemin Erten

1.1k total citations
65 papers, 809 citations indexed

About

Yasemin Erten is a scholar working on Nephrology, Physiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yasemin Erten has authored 65 papers receiving a total of 809 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Nephrology, 16 papers in Physiology and 12 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Yasemin Erten's work include Dialysis and Renal Disease Management (22 papers), Acute Kidney Injury Research (5 papers) and Nutrition and Health in Aging (5 papers). Yasemin Erten is often cited by papers focused on Dialysis and Renal Disease Management (22 papers), Acute Kidney Injury Research (5 papers) and Nutrition and Health in Aging (5 papers). Yasemin Erten collaborates with scholars based in Türkiye, United States and Cambodia. Yasemin Erten's co-authors include Ülver Derici, Hatîce Paşaoğlu, Şükrü Sindel, Kürşad Öneç, Gülay Ulusal Okyay, Salih İnal, Musa Bali, Özge Tuğçe Paşaoğlu, Galip Güz and Turgay Arınsoy and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gene and Journal of the American College of Nutrition.

In The Last Decade

Yasemin Erten

60 papers receiving 789 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yasemin Erten Türkiye 17 284 161 144 125 117 65 809
Giovanni Tripepi Italy 20 405 1.4× 154 1.0× 123 0.9× 64 0.5× 60 0.5× 66 1.1k
Shigeichi Shoji Japan 16 469 1.7× 279 1.7× 80 0.6× 70 0.6× 61 0.5× 59 982
Oleh M. Akchurin United States 13 469 1.7× 113 0.7× 166 1.2× 57 0.5× 139 1.2× 24 1.1k
Anna Challa Greece 22 174 0.6× 191 1.2× 166 1.2× 60 0.5× 88 0.8× 79 1.4k
Jesper Melchior Hansen Denmark 18 172 0.6× 226 1.4× 121 0.8× 78 0.6× 37 0.3× 50 1.1k
Francisco Veríssimo Veronese Brazil 23 548 1.9× 86 0.5× 115 0.8× 64 0.5× 58 0.5× 55 1.2k
Sun Ryoung Choi South Korea 18 527 1.9× 316 2.0× 214 1.5× 84 0.7× 65 0.6× 51 1.3k
Halil Önder Ersöz Türkiye 19 87 0.3× 92 0.6× 139 1.0× 60 0.5× 90 0.8× 56 1.2k
Sunna Snaedal Sweden 12 478 1.7× 199 1.2× 75 0.5× 43 0.3× 95 0.8× 16 862
Mesut Özkaya Türkiye 18 179 0.6× 133 0.8× 171 1.2× 57 0.5× 47 0.4× 70 1.1k

Countries citing papers authored by Yasemin Erten

Since Specialization
Citations

This map shows the geographic impact of Yasemin Erten's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yasemin Erten with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yasemin Erten more than expected).

Fields of papers citing papers by Yasemin Erten

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yasemin Erten. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yasemin Erten. The network helps show where Yasemin Erten may publish in the future.

Co-authorship network of co-authors of Yasemin Erten

This figure shows the co-authorship network connecting the top 25 collaborators of Yasemin Erten. A scholar is included among the top collaborators of Yasemin Erten based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yasemin Erten. Yasemin Erten is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Oğuz, Ebru Gök, Özant Helvacı, Hasan Selçuk Özger, et al.. (2024). Comparison of homologous and heterologous inactivated and mRNA vaccination programme against SARS‐CoV‐2 in dialysis patients. Nephrology. 29(7). 405–414. 1 indexed citations
3.
Depboylu, Gamze Yurtdaş, et al.. (2023). Association of Serum Adropin Levels with Nutritional Status and Lipid Profile in Patients with Kidney Failure with Replacement Therapy. SHILAP Revista de lepidopterología. 30(4). 1 indexed citations
4.
5.
Yıldıran, Hilal, et al.. (2018). Association of Malnutrition Inflammation Score With Anthropometric Parameters, Depression, and Quality of Life in Hemodialysis Patients. Journal of the American College of Nutrition. 38(5). 457–462. 22 indexed citations
6.
Şahin, Süleyman, Fatih Karataş, Hatîce Paşaoğlu, et al.. (2018). The Protective Effects of Pentoxifylline on Contrast Induced Nephropathy in Rats. 1 indexed citations
7.
İnal, Salih, Yasemin Erten, Gülay Ulusal Okyay, et al.. (2014). Association between bioimpedance analysis parameters and left ventricular hypertrophy in peritoneal dialysis patients. International Urology and Nephrology. 46(9). 1851–1856. 14 indexed citations
8.
Suyanı, Elif, Gülsan Türköz Sucak, Yasemin Erten, et al.. (2012). Evaluation of Multiple Myeloma Patients Presenting with Renal Failure in a University Hospital in the Year 2010. Renal Failure. 34(2). 257–262. 1 indexed citations
9.
Erten, Yasemin, Galip Güz, Ülver Derici, et al.. (2011). Association of the Angiotensinogen M235T and APO E Gene Polymorphisms in Turkish Type 2 Diabetic Patients with and without Nephropathy. Renal Failure. 33(5). 469–474. 14 indexed citations
10.
Mutluay, Rüya, Yasemin Erten, Hatîce Paşaoğlu, et al.. (2010). Predictive markers of asymptomatic atherosclerosis in end-stage renal disease patients. Renal Failure. 32(4). 448–454. 16 indexed citations
11.
Derici, Ülver, Cemalettin Aybay, Gülten Taçoy, et al.. (2009). The relationship between adiponectin levels and proinflammatory cytokines and left ventricular mass in dialysis patients. Journal of Nephrology. 22(2). 216–223. 21 indexed citations
12.
Erten, Yasemin, Hatîce Paşaoğlu, Canan Yılmaz, et al.. (2008). The Relationship of Visfatin Levels to Inflammatory Cytokines and Left Ventricular Hypertrophy in Hemodialysis and Continuous Ambulatory Peritoneal Dialysis Patients. Renal Failure. 30(6). 617–623. 13 indexed citations
13.
Derici, Ülver, et al.. (2008). TGF-β1 Gene Polymorphisms and Peritoneal Equilibration Test Results in CAPD Patients. Renal Failure. 30(1). 15–19. 5 indexed citations
14.
Mutluay, Rüya, et al.. (2007). A case with full clinical manifestations of Dorfman-Chanarin syndrome. Open Medicine. 2(1). 116–121. 2 indexed citations
15.
Erten, Yasemin, Murat Tulmaç, Ülver Derici, et al.. (2005). An Association Between Inflammatory State and Left Ventricular Hypertrophy in Hemodialysis Patients. Renal Failure. 27(5). 581–589. 31 indexed citations
16.
Ertoy, Dilek, Ergin Dileköz, Yasemin Erten, et al.. (2005). Effects of Amifostine on Glycerol‐Pretreated Rabbit Kidneys. Basic & Clinical Pharmacology & Toxicology. 97(3). 168–173. 1 indexed citations
17.
Bukan, Neslihan, et al.. (2004). Hemodiyaliz Hastalarında Serum Homosistein, Lipoprotein (a), Tümör Nekrozis Faktör-Alfa, Total Kolesterol Ve Trigliserid Düzeyleri. Turkiye Klinikleri Tip Bilimleri Dergisi. 24(5). 435–439. 1 indexed citations
18.
Erten, Yasemin, et al.. (1999). Long-term complications in patients surviving more than 10 years on hemodialysis. Transplantation Proceedings. 31(8). 3231–3232. 1 indexed citations
19.
Erten, Yasemin. (1998). Hemodiyalize giren kronik böbrek hastalarında ruhsal bozukluklar. Turkish Journal of Psychiatry. 9(1). 13–22. 4 indexed citations
20.
Turan, M, Fatma Nurhan Özdemir, Yasemin Erten, Nihan Haberal, & N Bi̇lgi̇n. (1996). HLA frequencies in the Turkish population and in end-stage renal disease patients.. PubMed. 28(4). 2349–50. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Giovanni Tripepi Breakdown of academic impact, for papers by Shigeichi Shoji Breakdown of academic impact, for papers by Oleh M. Akchurin Breakdown of academic impact, for papers by Anna Challa Breakdown of academic impact, for papers by Jesper Melchior Hansen Breakdown of academic impact, for papers by Francisco Veríssimo Veronese Breakdown of academic impact, for papers by Sun Ryoung Choi Breakdown of academic impact, for papers by Halil Önder Ersöz Breakdown of academic impact, for papers by Sunna Snaedal Breakdown of academic impact, for papers by Mesut Özkaya
Rankless by CCL
2026